Protokoly_diagnostiki_i_lechenia_zabolevany

7. " – $#$ & (10% - $ 10-15 1 , 1 >@ 3 . , 1,0 . 1 % ),75-100 , "& 200-400- 800 / / / , 0,4-0,8 . , 0,025 -0,05 -0,1 . / / -1 &. 10-20 / / , 3 ; 1 -3&; 1-3 3 1-2 / -1-2

0,125-0,5 3 & 10 , / 1,875 3 10 ; 3 0,4-1,0 4 10 , 10 / 1&, 3 , 1,5-9,0 . 6> 10 , 5 / / 2 10 , 15/ / / . 2 10 , 20- 50-100 / / , 50-100 / / . 4 10-14 ; 50-100 / / . 3-4 10-14 ; 50-100 / / ., 0,1-0,2 5&, 6-12 / /

10.? – 3 5-10 / / , 0,05- 0,250 / , 50-100 / .

11.& – + '! ( ): 60100 , 2,0 . , 2-2,5-3 / / .,2-3 / / ., 30-40 / / ., 10-20 / / .,5 / / .

12.$ – ( ) 0,5-1,0 / / 2-3$# % 2,5 $, "" " " – $ .

"$# # , –, , 3 , 2,5-15 2-3 ;– 250 3 / , 200-400 2 ,0,5-1,0 , 100 3 , 0,15-0,25 . 3&, ' & 1 . 2-3 &,, " & V 5, 10 20 .50-75 , 10-15 .

" & :

1.*@ 62,5 , 250 , .; 0,025% 1 , ;

2.*_ 40 , .; 20 /2 , .;

3.*7 2,5 , 10 , .; 1,25 /1 , .;

4.* 40 , ;

5.*? 200 , .; 150 /3 , .;

6.*J 1%, 2%, 10% ( ) 2 , 10 , V ;

7.*' 40 , 80 , .;

8. $ 5%, 10% 400 , 500 ; 40% 5 , 10 .;

9.1,0 .;

10.*@ "& 200 , V ; 40 / 10%, 20% ;

11.*' 2,5 .;

12.*? 500 , 1000 , .; 250 ; 500 , .; 250 /5 &;

13.*? / 625 , .; 600 , , V ;

14. *7 250 , 500 , .; 250 /5 & ;

15.*? 125 , 500 .; 250 .; 200 /100 ;

16.*/ 1000 , V ;

17.*/ 250 , 500 . .; 125 , 250 /5 ;

18.*? 200 ,800 .;

19.*_50 , 150 .; 100 / ;

20.7 250 .;

21.*? 50 , 100 , 500 .; 5%, 10% 2 , 5V ;

22.*? 100 , 250 , 325 , 500 ;

23.* 5 .; 30 / V ;

24.*@ 2 , 5 , .;

25.* 200 .; 20% 5 .;

26.* , " & 5, 10 20 V .

" & & :

1.*! 25 , 50 .;

2.* 50 .;

3.*? 50 , 100 .;

4.*? 1% 1 ;

5.75-100 ;

6. 50 V ;

7.100 , 200 ;

8._ 100-200 .;

9.*! 1,5 >@, 375 >@, 750 >@ ; 1,5 >@,;

10.* 250 , 500 ;

11.*/ 250 , 500 , .; 750 , V;

12.*/ 250 , 500 , 1 000 , , V ;

14., , 3 50 ;

15.*' 5 , 10 .; 2 .;

16.250 .

% , %$# $3 " .

% , "- & " , % % ," " " , #B; .

/ , & :

1.K '. . # . 2005. http://www.infarktu.net/catalog/professional/13/articles/

2.< ;.'. . + ".

?6+, .6 . 2001. http://www.ortho.ru

3.Gewllig M, Mertens L, Moerman P, et al. Idiopathic restrictive cardiomyopathy in childhood. Eur Heart J 1996;

4.!G. Cardiomyopathy. Dilated. 2005. http://www.clinicalevidence.com

5.R. E. Manzur, G. Barbieri Chronical Chagas Illnes: Controversial aspects about its ethiological treatment. Center of Chagas Illness and Regional Pathology "Dr. Humberto Lugones" , Santiago del Estero, Argentina. 2003. http://www.yahoo.com

6.>.>. B . 7 & "

8 &

: 05-056

"$ &: " :

& ! :

& "- " , % % , " " & " & (7 , , 7 ) ,, "

' & & ( ): 20

(:

I34.0 6 & " & ( " )

I34.2 + " &

I34.1 ( ) &

I34.9 + " % & "

) :

+ " % & – % & " 3 , $" .

6 & – % -% " , $#" % " . 6 & " & – & -% "& %$ % "% "& – " ( )

& % "

$ :

-& " &;

-& ;

-& " & ;

-6 .

* :

1. - & ;

2.;

3.3 ;

4.% (3 , , );

5.& ;

" : , 3 .

" :

1." # II-III ;

2.% % ;

3.% .

I :

1. & " & % & & %

# & , " & " , % "$ ;

2. , " , & , " &$ ;

3.« " » , " " ,;

4. I , II " ,& III , " " - , $# , " & .

1.# , " " , " .

III$ :

1.% " , % " .

2.% " ;

3.& " % .

& : I :

1.% $, % & % " - , " " , 3.

2.% " , , ,

4.$# I , " "

" & , # II " , & " .

1.# , " "% " , " .

III$ :

1.– , , # I, II VL , V1, V2 "

1.? &- - " # " " " , - " # " , " ;

2.& " 3- " &$# 3 " ;

3.3 "- # & " ,% " " "

, " 3 .

' & :

1." - " , 3 & & &, "& 1 .

2.& - - " # " ;

3." – , " % , " ;

4." – , " ;

5. 3 " – " (2 ), " (3 ) " ; " $" .

$ :

1." – , &, % , , ,;

2.3 " - ; II, III, aVF" ;

3.3 "- " &

( 3 ) " ; 4. - % " 3 ,

& .

" & :

1.# (6 );

2.7

3.7 , ;

4.& ;

5.& ;

6./ ;

7.!- ;

8.?!J ;

9.2- # ;

10.H)B $ ;

11.;

12.?J;;

13.?!;;

14.;

15.;

16.;

17." ;

18.;

19.# " .

" & & :

1. L # 3 ;

2.G 7 ;

3.% ;

4.H)B ;

5.!-3 ;

6.' 3 ;

7., ;

8.& ;

9.;

10., ;

11.3 ;

12.7 3 ;

13.7 3 ;

14.& ;

15.&

16.;

17." % ;

18." & ;

19.B_? .

7." # : " - "" # ¨¨- %$# 0,008-0,01 / / 2 ; "

# – 1-3 / / 3 3,3 / / 2-3 1-2 / / ., ?_: 3 2,5-5-10 / 2 ( & ) 0,3-1,0 / / 3 .

8. ? : 2,5-5,0 / , 2 " 3 ,$ ( % & 1,5-2

;

4.* 250 , 500 ;

5.*/ 250 , 500 , 1 000 , , V ;

6. *B 500 , V ;

7.* ? 50 , 100 .;

8.* ' 40 , 80 , .;

9.* ? 1% 1 ;

10.*! 25 , 50 .;

11.* @ 200 , 400

12.B 25 .;

13.+ , 3 30 ;

14.*' 5 , 10 .; 2 .;

,- ! :

& ( ) "- " , % % , " " & " & (7 , , 7 ) -3 " .

< & & " " & & " " .

G " " 6+ $# " :

- " % " , &

-" &

-" " ( " 50 . .60 . . )

-" % " % " ( JD30%, " " JD 55 )

; & &.

/ , & :

1 " + " " : . B.+.@ , M.J. K " – 6.: 7 ;?-6>@, 2004. – 1184 . ( «@ & 6 »)

2.ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)

3.Scottish Intercollegiate Guidelines Network A National Clinical Guideline Antithrombotic Therapy March 1999

4.Management of Patients WithValvular Heart Disease A Report of the American College ACC/AHA Pocket GuidelinesA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines July 2000

5.Mitral Valve Prolapse: Time for a Fresh Look. Reviews in Cardiovascular Medicine 2001; 2(2): 73-

81.Guidelines: https://www.americanheart.org

* – , # (% % )

, , & , " " & " & (7 , , 7 ) .

' & & ( ): 25

(: I40

I09.0 "

I09.2 G " "

) : ) - 3 %& & / , $#" & & .

$ :

" :

-' % : ; -.

$:

-; - -& ; -& ;

-; -; -" ;

-" .

* ( - ):

-;

-% # .

+ :

-;

-;

-" .

+ 8 & :

- ; -% ; -% .

* & :

-% " I, II?, II<, III;

-% " I, II?, II<, III;

-& II<, III.

> 8 : - ; -; - ;

- ;